JOBS Act spurs biotech IPOs; could keep bubble from bursting
This article was originally published in Scrip
Executive Summary
Is an initial public offering bubble inflating and at risk of popping on the whims of the fickle financial markets? Many in the biotechnology industry have begun to question when the boom will bust.